NCT04264234

Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

Completed NA Last updated 23 March 2022

What this trial tests

NA trial testing Vaginal Ultrasonography in Placenta Previa in 98 participants. Completed in 1 February 2020.

Timeline

13 November 2018

Primary endpoint
1 February 2020

1 February 2020

Quick facts

Lead sponsor	Ege University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	98
Start date	13 November 2018
Primary completion	1 February 2020
Estimated completion	1 February 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Vaginal Ultrasonography
• Magnetic Resonance Imaging

Conditions studied

• Placenta Previa — all drugs for Placenta Previa →

Sponsor

Ege University

Who can join

Eligibility, female only, with Placenta Previa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.